Hjem › Neuroblastom › Connecticut › Hartford
Kliniske studier for Neuroblastom i Hartford, CT
8 studier for Neuroblastom søker deltakere på steder i og rundt Hartford (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- Connecticut Children's Medical Center, Hartford
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
RekruttererFase 2
- Connecticut Children's Hospital, Hartford
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekruttererFase 1/2
- Connecticut Children's Hospital, Hartford
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruttererFase 1/2
- Connecticut Children's Hospital, Hartford
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
RekruttererFase 2
- Connecticut Children's Hospital, Hartford
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruttererFase 3
- Connecticut Children's Medical Center, Hartford
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
RekruttererFase 2
- Connecticut Children's Hospital, Hartford
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Rekrutterer
- Connecticut Children's Medical Center, Hartford
Neuroblastom-studier i andre byer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- Dallas, TX9 studier
- St. Louis, MO9 studier
- Aurora, CO8 studier
- Minneapolis, MN8 studier
- Birmingham, AL8 studier
- Atlanta, GA7 studier
- San Francisco, CA7 studier
Andre studier i Hartford
- Ikke-småcellet lungekreft12 studier
- Lungekreft11 studier
- Major depresjon9 studier
- Kreft (alle typer)9 studier
- Brystkreft9 studier
- Multipelt myelom7 studier
- Pankreaskreft7 studier
- Prostatakreft7 studier
- Eggstokkreft7 studier
- Kardiovaskulær sykdom7 studier
- Hjertesvikt7 studier
- Sigdcelleanemi5 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.